WeChip Biotechnology (688321.SH) released its first quarter financial results, with a net loss attributable to shareholders of 19.15 million yuan, widening the loss.

Tencent Finance APP News, Weixin Biology (688321.SH) released the first quarter report for 2025, with a revenue of 162 million yuan in the first quarter, a year-on-year increase of 24.24%; the net loss attributable to the shareholders of the listed company was 19.1547 million yuan, expanding the loss; the net loss attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 24.5835 million yuan, expanding the loss; basic loss per share was 0.0470 yuan/share.